Acorda Therapeutics Inc (ACORQ)
OTCMKTS: ACORQ · Delayed Price · USD
0.339
0.00 (0.00%)
Apr 17, 2024, 12:00 AM EDT - Market open
Acorda Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 117.63 | 118.57 | 129.07 | 152.97 | 192.41 | 471.43 | 588.29 | 519.6 | 492.66 | 401.48 | Upgrade
|
Revenue Growth (YoY) | -0.79% | -8.14% | -15.62% | -20.50% | -59.19% | -19.86% | 13.22% | 5.47% | 22.71% | 19.34% | Upgrade
|
Cost of Revenue | 15.28 | 30.33 | 40.79 | 33.51 | 34.85 | 97.64 | 111.96 | 108.11 | 92.93 | 80.62 | Upgrade
|
Gross Profit | 102.35 | 88.23 | 88.28 | 119.45 | 157.56 | 373.79 | 476.33 | 411.49 | 399.73 | 320.87 | Upgrade
|
Selling, General & Admin | 89.7 | 106.26 | 124.4 | 152.58 | 192.85 | 172.25 | 181.62 | 235.44 | 205.63 | 201.81 | Upgrade
|
Research & Development | 5.15 | 5.8 | 10.42 | 23.01 | 60.08 | 106.38 | 166.11 | 203.44 | 149.21 | 73.47 | Upgrade
|
Other Operating Expenses | 282.09 | 18.21 | 30.76 | 92.79 | 303.2 | 1.67 | 320.52 | -9.9 | -0.41 | 6.99 | Upgrade
|
Operating Expenses | 376.94 | 130.27 | 165.58 | 268.38 | 556.13 | 280.31 | 668.25 | 428.97 | 354.43 | 282.27 | Upgrade
|
Operating Income | -274.59 | -42.04 | -77.3 | -148.92 | -398.57 | 93.49 | -191.91 | -17.48 | 45.3 | 38.59 | Upgrade
|
Interest Expense / Income | 31.53 | 30.2 | 30.04 | 30.57 | 21.87 | 21.6 | 18.66 | 16.53 | 15.47 | 9.29 | Upgrade
|
Other Expense / Income | -10.1 | -36.99 | 1.74 | -71.83 | -146.19 | 51.47 | 41.31 | 7.28 | 10.46 | 1.29 | Upgrade
|
Pretax Income | -296.02 | -35.25 | -109.07 | -107.67 | -274.25 | 20.42 | -251.89 | -41.28 | 19.37 | 28.01 | Upgrade
|
Income Tax | -43.17 | 30.67 | -5.12 | -8.07 | -1.28 | -13.26 | -28.53 | -6.67 | 8.31 | 10.34 | Upgrade
|
Net Income | -252.85 | -65.92 | -103.95 | -99.59 | -272.97 | 33.68 | -223.36 | -34.62 | 11.06 | 17.67 | Upgrade
|
Net Income Growth | - | - | - | - | - | - | - | - | -37.43% | 7.49% | Upgrade
|
Shares Outstanding (Basic) | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Outstanding (Diluted) | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Change | 22.85% | 90.38% | 31.38% | 1.98% | 0.47% | 2.92% | 1.64% | 3.76% | 2.53% | 2.07% | Upgrade
|
EPS (Basic) | -203.57 | -65.23 | -195.80 | -246.40 | -688.60 | 86.40 | -583.20 | -91.20 | 31.20 | 51.60 | Upgrade
|
EPS (Diluted) | -203.57 | -65.23 | -195.80 | -246.40 | -688.60 | 85.20 | -583.20 | -91.20 | 30.00 | 50.40 | Upgrade
|
EPS Growth | - | - | - | - | - | - | - | - | -40.48% | 7.69% | Upgrade
|
Free Cash Flow | -14.25 | -21.06 | -41.51 | -65.4 | -218.59 | 117.47 | 83.45 | 23.46 | 32.56 | 69.57 | Upgrade
|
Free Cash Flow Per Share | -11.47 | -20.83 | -78.17 | -161.79 | -551.51 | 299.85 | 217.69 | 62.19 | 92.52 | 202.86 | Upgrade
|
Gross Margin | 87.01% | 74.42% | 68.40% | 78.09% | 81.89% | 79.29% | 80.97% | 79.19% | 81.14% | 79.92% | Upgrade
|
Operating Margin | -233.43% | -35.45% | -59.89% | -97.36% | -207.15% | 19.83% | -32.62% | -3.36% | 9.20% | 9.61% | Upgrade
|
Profit Margin | -214.95% | -55.59% | -80.54% | -65.11% | -141.87% | 7.14% | -37.97% | -6.66% | 2.24% | 4.40% | Upgrade
|
Free Cash Flow Margin | -12.11% | -17.76% | -32.16% | -42.75% | -113.61% | 24.92% | 14.18% | 4.51% | 6.61% | 17.33% | Upgrade
|
Effective Tax Rate | - | - | - | - | - | -64.92% | - | - | 42.91% | 36.91% | Upgrade
|
EBITDA | -232.89 | 27.76 | -45.09 | -35.8 | -217.8 | 53.5 | -209.99 | -3.17 | 49.85 | 45.77 | Upgrade
|
EBITDA Margin | -197.98% | 23.41% | -34.93% | -23.40% | -113.20% | 11.35% | -35.69% | -0.61% | 10.12% | 11.40% | Upgrade
|
Depreciation & Amortization | 31.6 | 32.81 | 33.95 | 41.3 | 34.57 | 11.48 | 23.23 | 21.58 | 15.01 | 8.47 | Upgrade
|
EBIT | -264.49 | -5.05 | -79.04 | -77.09 | -252.38 | 42.02 | -233.22 | -24.76 | 34.84 | 37.3 | Upgrade
|
EBIT Margin | -224.84% | -4.26% | -61.24% | -50.40% | -131.17% | 8.91% | -39.64% | -4.76% | 7.07% | 9.29% | Upgrade
|